Related references
Note: Only part of the references are listed.Challenges in detection and treatment of multidrug resistant tuberculosis patients in Vietnam
Thuy Thi Thanh Hoang et al.
BMC PUBLIC HEALTH (2015)
Transmission of Multidrug-Resistant and Drug-Susceptible Tuberculosis within Households: A Prospective Cohort Study
Louis Grandjean et al.
PLOS MEDICINE (2015)
Multidrug-resistant tuberculosis around the world: what progress has been made?
Dennis Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis
Kuldeep Singh Sachdeva et al.
PLOS ONE (2015)
Risk of Tuberculosis after Recent Exposure A 10-Year Follow-up Study of Contacts in Amsterdam
Rosa Sloot et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Treatment outcomes from community-based drug resistant tuberculosis treatment programs: a systematic review and meta-analysis
Pamela Weiss et al.
BMC INFECTIOUS DISEASES (2014)
Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis
Peter MacPherson et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2014)
The Temporal Dynamics of Relapse and Reinfection Tuberculosis After Successful Treatment: A Retrospective Cohort Study
Florian M. Marx et al.
CLINICAL INFECTIOUS DISEASES (2014)
Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis
J. Peter Cegielski et al.
CLINICAL INFECTIOUS DISEASES (2014)
Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis
A. S. Dharmadhikari et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2014)
Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-pacific
James M. Trauer et al.
JOURNAL OF THEORETICAL BIOLOGY (2014)
Prescription patterns and treatment outcomes of MDR-TB patients treated within and outside the National Tuberculosis Programme in Pham Ngoc Thach hospital, Viet Nam
Nguyen B. Hoa et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2014)
Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis
Sourya Shrestha et al.
OPEN FORUM INFECTIOUS DISEASES (2014)
Is Passive Diagnosis Enough? The Impact of Subclinical Disease on Diagnostic Strategies for Tuberculosis
David W. Dowdy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Contact investigation for tuberculosis: a systematic review and meta-analysis
Gregory J. Fox et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis
A. Toczek et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Assessment of tuberculosis burden in China using a dynamic disease simulation model
M. Mehra et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)
Universal access to care for multidrug-resistant tuberculosis: an analysis of surveillance data
Dennis Falzon et al.
LANCET INFECTIOUS DISEASES (2013)
Tuberculosis Recurrence after Completion Treatment in a European City: Reinfection or Relapse?
Juan-Pablo Millet et al.
PLOS ONE (2013)
Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa
Kathryn Schnippel et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2013)
Risk of Progression to Active Tuberculosis Following Reinfection With Mycobacterium tuberculosis
Jason R. Andrews et al.
CLINICAL INFECTIOUS DISEASES (2012)
Implementing the Global Plan to Stop TB, 2011-2015-Optimizing Allocations and the Global Fund's Contribution: A Scenario Projections Study
Eline L. Korenromp et al.
PLOS ONE (2012)
Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic Evaluation
Nicolas A. Menzies et al.
PLOS MEDICINE (2012)
Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic Review
Edine W. Tiemersma et al.
PLOS ONE (2011)
Revisiting Rates of Reactivation Tuberculosis A Population-based Approach
C. Robert Horsburgh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
National survey of tuberculosis prevalence in Viet Nam
Nguyen Binh Hoa et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2010)
Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
James C. Johnston et al.
PLOS ONE (2009)
Effect of Duration and Intermittency of Rifampin on Tuberculosis Treatment Outcomes: A Systematic Review and Meta-Analysis
Dick Menzies et al.
PLOS MEDICINE (2009)
Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis
Dick Menzies et al.
PLOS MEDICINE (2009)
Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens
Anton Mak et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testing
David W. Dowdy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Timing of default from tuberculosis treatment: a systematic review
Margaret E. Kruk et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
Epidemiology of tuberculosis in a high HIV prevalence population provided with enhanced diagnosis of symptomatic disease
Elizabeth L. Corbett et al.
PLOS MEDICINE (2007)
Time to sputum culture conversion in multidrug-resistant tuberculosis: Predictors and relationship to treatment outcome
TH Holtz et al.
ANNALS OF INTERNAL MEDICINE (2006)
Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance
SM Blower et al.
NATURE MEDICINE (2004)
Criteria for the control of drug-resistant tuberculosis
C Dye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
